Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

PARSLEY HEALTH RAISES $26 MILLION SERIES B

Published October 18, 2019
Published October 18, 2019
Parsley Health

Parsley Health, the leading national provider of holistic personalized medicine designed to reverse chronic illness and optimize health, closed a $26 million Series B round of funding led by White Star Capital.

WHO: Parsley Health is a new kind of digital health company offering personalized medical services across telemedicine, diagnostics, and in-person care. Parsley’s unique approach blends cutting-edge testing, nutrition, wellness, and prevention with conventional medicine. It is the first and only vertically integrated digital health solution for reversing chronic disease and optimizing health. The company was founded in 2016 by Dr. Robin Berzin, MD, a Columbia-trained physician, digital health expert, and leader in holistic medicine.

WHY: Parsley Health will use this latest funding to hire additional doctors and team members, expand to new cities, and increase its remote services.

IN THEIR OWN WORDS: “Our health system desperately needs a makeover. According to the CDC, 60% of American adults have at least one chronic disease—that’s 153 million people. These are largely lifestyle-driven, preventable and reversible conditions and yet they account for 90% of our annual healthcare costs,” Dr. Robin Berzin, CEO & Founder of Parsley Health said in a statement. “A revolving door of prescriptions, referrals to specialists and band-aid solutions won’t fix this and it won’t fix us. We need a new model of care, one that’s accessible, affordable, proven to address the root causes of chronic disease and—thanks to technology—available from anywhere around the globe.”

“Parsley Health’s unique model not only fosters a better, stronger relationship between health practitioners and patients but addresses the strong demand for functional medical services and easier access with their organic tech integration. We believe in Parsley’s noble mission and continue to be impressed by its fast-growth in the US and its model that enables the company to generate multi-channel revenue from care memberships to e-commerce,” White Star Capital Founder and Managing Partner, Eric Martineau-Fortin, said in a statement. “With this new investment, we are incredibly excited to work with the Parsley team to help further scale its modern personalized approach—a critical need of the healthcare industry across the world.”

“Parsley Health is delivering the future of primary care,” said Nat Turner, Founder and CEO of Flatiron Health. “From the advanced clinical model designed to reduce chronic illness while optimizing health, to the tech-enabled consumer-grade user experience, they are proving novel ways to improve outcomes and lower costs. I’m proud to join them again as an investor in their latest round of funding and to watch the company scale nationally.”

DETAILS:

  • Parsley closed a $26 million Series B round of funding.
  • The round was led by White Star Capital, with participation from FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Trail Mix Ventures, and Galaxy Digital. Flatiron Health founder Nat Turner and One Medical founder Tom Lee also participated in the round.
  • Parsley raised a $10 million Series A in spring 2018 led by FirstMark Capital. Individual investors also included Mark Hyman, MD, director of the Cleveland Clinic Center for Functional Medicine; Nat Turner, CEO of Flatiron Health; Neil Parikh, cofounder of Casper; and Dave Gilboa, cofounder of Warby Parker.
×

2 Article(s) Remaining

Subscribe today for full access